Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Riociguat API Suppliers & Bulk Manufacturers

Available Forms: API (drug substance)

Available Strengths: Supplied to an in-house or pharmacopoeial specification

Reference Brands: Adempas

Category: Active Pharmaceutical Ingredient

Riociguat is an oral soluble guanylate cyclase stimulator for pulmonary hypertension. It is sourced by generic formulators, CDMOs and licensed importers preparing generic tablets.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Riociguat API? List it or send an offer →

Product Description:

Riociguat stimulates soluble guanylate cyclase, the enzyme that nitric oxide normally switches on, raising cyclic GMP so that the blood vessels in the lungs relax. It is approved for adults with chronic thromboembolic pulmonary hypertension that is inoperable or persists after surgery, and for pulmonary arterial hypertension (WHO Group 1) (reference brand: Adempas).

Specification at a glance

Traded formFree base; white to yellowish, crystalline and non-hygroscopic, with strongly pH-dependent solubility.
CAS number625115-55-1
Molecular formulaC20H19FN8O2
Molecular weight422.4 g/mol
PharmacopoeiaEDQM supplies a riociguat Ph. Eur. reference standard, which points to a Ph. Eur. text (not verified against the Ph. Eur. itself). No USP or JP monograph found.

Regulatory files and timing

The FDA list of Drug Master Files (third quarter 2026) shows 6 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.

Generic or biosimilar entry. United States: Generics/biosimilars on the market (Oct 2026). European Union: Patent expiry; entry not confirmed (2028).

Handling and quality points

The label describes solid riociguat as stable to temperature, light and humidity, so storage is straightforward. More attention goes on crystal form, as more than one solid form is known, and on particle size, because the tablets contain very little drug and content uniformity depends on it. Riociguat carries an embryo-foetal toxicity warning, so occupational exposure controls and suitable containment for weighing and blending apply.

Send an API enquiry All specialty APIs

Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.

Riociguat API — third party manufacturing & bulk supply

Riociguat API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Riociguat API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Riociguat API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Riociguat API →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

A GMP certificate, specification and certificate of analysis, and a US DMF letter of access, EU ASMF or CEP if one is available. Buyers also ask for solid-form and particle size data, stability results, and nitrosamine and residual solvent risk assessments.

Riociguat can exist in more than one crystalline form, and the reference product uses one defined form. Ask the supplier which form it makes, how it is confirmed by XRPD, and whether the material is milled or micronised to a set particle size distribution suited to low-strength tablets.

It can. We connect licensed manufacturers, CDMOs and research teams with GMP-compliant riociguat makers, and we check the supplier's paperwork before passing on an enquiry. Your company stays anonymous until both sides are happy to proceed.

Related Products

Carfilzomib API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Kyprolis

View Details
Acalabrutinib API

Strength:
USP grade or in-house specification

Form: API (drug substance)

Reference Brands: Calquence

View Details
Niraparib Tosylate Monohydrate API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Zejula

View Details
Ferumoxytol API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Feraheme, Rienso

View Details
Monomethyl Auristatin E (MMAE) API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Adcetris, Padcev, Polivy, Tivdak

View Details
Fidaxomicin API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Dificid, Dificlir

View Details
Nivolumab Drug Substance

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: Drug substance (bulk)

Reference Brands: Opdivo

View Details
Benralizumab Drug Substance

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: Drug substance (bulk)

Reference Brands: Fasenra

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us